ATE257648T1 - Definierte medizinische lösung ohne serum für die augenheilkunde - Google Patents
Definierte medizinische lösung ohne serum für die augenheilkundeInfo
- Publication number
- ATE257648T1 ATE257648T1 AT99308702T AT99308702T ATE257648T1 AT E257648 T1 ATE257648 T1 AT E257648T1 AT 99308702 T AT99308702 T AT 99308702T AT 99308702 T AT99308702 T AT 99308702T AT E257648 T1 ATE257648 T1 AT E257648T1
- Authority
- AT
- Austria
- Prior art keywords
- supplements
- nutrient
- solution
- growth factor
- medical solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides or bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C12N2501/392—Sexual steroids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/186,580 US6153582A (en) | 1998-11-05 | 1998-11-05 | Defined serumfree medical solution for ophthalmology |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE257648T1 true ATE257648T1 (de) | 2004-01-15 |
Family
ID=22685497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99308702T ATE257648T1 (de) | 1998-11-05 | 1999-11-02 | Definierte medizinische lösung ohne serum für die augenheilkunde |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6153582A (de) |
| EP (1) | EP1000541B1 (de) |
| JP (1) | JP2000198701A (de) |
| AT (1) | ATE257648T1 (de) |
| AU (1) | AU769082B2 (de) |
| CA (1) | CA2288540C (de) |
| DE (1) | DE69914160T2 (de) |
| ES (1) | ES2217700T3 (de) |
| PT (1) | PT1000541E (de) |
Families Citing this family (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6849612B2 (en) * | 1993-01-21 | 2005-02-01 | Isis Pharmaceuticals, Inc. | Oligonucleotide modulation of cell adhesion |
| US20070231402A1 (en) * | 1994-08-02 | 2007-10-04 | Immunopath Profile, Inc. | Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof |
| US6974796B1 (en) | 1999-08-17 | 2005-12-13 | Girsh Leonard S | Therapeutic compositions for treatment of a damaged tissue |
| US20070037777A1 (en) * | 2005-08-12 | 2007-02-15 | Immunopath Profile, Inc. | Lipid-containing compositions and methods of using them |
| US7790678B1 (en) | 1999-08-17 | 2010-09-07 | Immunopath Profile, Inc. | Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use |
| US20090274660A1 (en) | 1999-08-17 | 2009-11-05 | Immunopath Profile, Inc. | Pluripotent therapeutic compositions and uses thereof |
| WO2001056594A1 (en) | 2000-02-04 | 2001-08-09 | Unigene Laboratories, Inc. | Nasal calcitonin formulations |
| US7611830B2 (en) * | 2000-04-10 | 2009-11-03 | The United States Of America As Represented By The Department Of Veteran's Affairs | Device to lavage a blood vessel |
| US6569615B1 (en) * | 2000-04-10 | 2003-05-27 | The United States Of America As Represented By The Department Of Veteran's Affairs | Composition and methods for tissue preservation |
| US6762053B2 (en) * | 2000-06-09 | 2004-07-13 | Vitrolife, Inc. | Mammalian gamete and embryo culture media and culture media supplements |
| KR100612398B1 (ko) * | 2000-11-14 | 2006-08-16 | 바이탈 헬스 사이언시즈 피티와이 리미티드 | 포스페이트 유도체의 착체 |
| AUPR549901A0 (en) | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
| GB0028414D0 (en) | 2000-11-22 | 2001-01-03 | Univ Leeds | Flush preservation solution |
| DE10133196A1 (de) * | 2001-07-07 | 2003-01-23 | Beiersdorf Ag | Nicotinsäure enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut |
| AU2002317053B2 (en) | 2001-07-27 | 2004-08-05 | Vital Health Sciences Pty Ltd | Dermal therapy using phosphate derivatives of electron transfer agents |
| WO2003022046A1 (en) * | 2001-09-10 | 2003-03-20 | University Of Saskatchewan Technologies Inc. | Method for cryopreserving mammalian cells and tissues |
| US7247239B2 (en) * | 2001-11-16 | 2007-07-24 | Technocon Gmbh | Method for biological treatment of water by adding macromolecular carbohydrates |
| BRPI0307074A2 (pt) * | 2002-01-25 | 2017-06-20 | Genzyme Corp | meios sem soro para condrócitos e métodos para seu uso |
| CA2475356A1 (en) * | 2002-02-12 | 2003-08-21 | Raven Biotechnologies, Inc. | Human fetal bladder-derived epithelial cells |
| AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
| EP1475434A1 (de) * | 2003-05-09 | 2004-11-10 | Oncoscience AG | Verfahren zur Lagerung von Tumorzellen |
| FR2856891B1 (fr) * | 2003-07-04 | 2007-09-07 | Stem Alpha | Milieu de conservation d'organes, de tissus biologiques ou de cellules vivantes |
| US20050176144A1 (en) * | 2004-02-06 | 2005-08-11 | O'daly Jose A. | Culture media compositions free of fetal bovine serum |
| CA2557354C (en) | 2004-03-03 | 2013-05-07 | Vital Health Sciences Pty Ltd. | Alkaloid formulations |
| BRPI0400935A (pt) * | 2004-04-02 | 2005-11-22 | Ernesto Rodriguez Salas | Solução para conservação de membranas biológicas e seu uso |
| JP2005306749A (ja) * | 2004-04-19 | 2005-11-04 | Kringle Pharma Inc | Ｈｇｆ含有臓器保存液 |
| US8252591B2 (en) | 2004-05-07 | 2012-08-28 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
| US11660317B2 (en) | 2004-11-08 | 2023-05-30 | The Johns Hopkins University | Compositions comprising cardiosphere-derived cells for use in cell therapy |
| WO2006092449A2 (en) | 2005-03-02 | 2006-09-08 | Metanomics Gmbh | Process for the production of fine chemicals |
| US7601487B2 (en) * | 2005-04-12 | 2009-10-13 | Cleo Cosmetic And Pharmaceutical Co., Llc | Composition using HMW dextran and method for in vitro preservation of corneal tissues |
| MX2007015949A (es) | 2005-06-17 | 2008-03-07 | Vital Health Sciences Pty Ltd | Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos. |
| CN100362098C (zh) * | 2005-09-29 | 2008-01-16 | 华东理工大学 | 适用于多种动物细胞大规模培养的无血清培养基 |
| US20070224588A1 (en) * | 2006-03-22 | 2007-09-27 | Biocept, Inc. | Trophoblast preservation/pretreatment medium and method |
| WO2007138119A1 (es) * | 2006-05-30 | 2007-12-06 | Instituto Nacional De Investigación Y Tecnología Agraria Y Alimentaria, Inia | Procedimiento de preparación de vesículas unilamelares para la criopreservación y cultivo de celulas germinales y embriones |
| CN100463681C (zh) * | 2006-10-24 | 2009-02-25 | 北京紫竹药业有限公司 | 一种治疗干眼症的人工泪液 |
| CN105123670B (zh) | 2007-02-17 | 2018-12-14 | 哈佛学院董事会 | 用于进行组织保存的组合物以及方法 |
| EP2188367A4 (de) | 2007-08-10 | 2010-10-27 | Whitehead Biomedical Inst | Auf hormon ansprechendes gewebekultursystem und verwendungen davon |
| CA2715634A1 (en) | 2008-02-15 | 2009-08-27 | President And Fellows Of Harvard College | Blood substitute solution |
| JP5663841B2 (ja) * | 2009-02-23 | 2015-02-04 | 富士レビオ株式会社 | 骨細胞への分化誘導培地及び方法 |
| CN101524063B (zh) * | 2009-03-23 | 2012-06-13 | 姚晓明 | 角膜中期保存液 |
| NZ598171A (en) | 2009-07-10 | 2014-11-28 | Linzy O Scott Iii | Methods and compositions for treating thyroid-related medical conditions with reduced folates |
| FR2948286B1 (fr) * | 2009-07-27 | 2011-08-26 | Jean-Noel Thorel | Composition injectable associant un agent de comblement et un milieu de croissance des fibroblastes |
| JP5681472B2 (ja) * | 2009-12-28 | 2015-03-11 | ロート製薬株式会社 | 眼科用組成物 |
| US10071030B2 (en) | 2010-02-05 | 2018-09-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| WO2011103114A1 (en) * | 2010-02-17 | 2011-08-25 | Hememics Biotechnologies, Inc. | Preservation solutions for biologics and methods related thereto |
| JP5806287B2 (ja) | 2010-03-30 | 2015-11-10 | フォスファジェニクス リミティド | 経皮送達パッチ |
| US9845457B2 (en) * | 2010-04-30 | 2017-12-19 | Cedars-Sinai Medical Center | Maintenance of genomic stability in cultured stem cells |
| WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| US9481861B2 (en) | 2011-07-12 | 2016-11-01 | Foodchek Systems, Inc. | Culture medium, method for culturing Salmonella and E. coli and method for detecting Salmonella and E. coli |
| AU2013302799B2 (en) | 2012-08-13 | 2018-03-01 | Cedars-Sinai Medical Center | Exosomes and micro-ribonucleic acids for tissue regeneration |
| WO2014070769A1 (en) | 2012-10-29 | 2014-05-08 | The University Of North Carolina At Chapel Hill | Methods and compositions for treating mucosal tissue disorders |
| EP2938186B1 (de) * | 2012-12-31 | 2019-02-06 | Somahlution, LLC | Organ- und gewebekonservierungsformulierungen mit erhöhter stabilität und haltbarkeit |
| CN103190392B (zh) * | 2013-03-28 | 2015-07-29 | 北京大学第三医院 | 一种角膜中期保存液及其制备方法 |
| US10350232B1 (en) | 2013-11-04 | 2019-07-16 | Peter D. Jaillet | Medicinal drops |
| JP2016537333A (ja) | 2013-11-22 | 2016-12-01 | ソマールション・エルエルシー | 臓器組織保存溶液の安定性及び保存可能期間を増加させる溶液 |
| WO2016054591A1 (en) | 2014-10-03 | 2016-04-07 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy |
| CN107206003B (zh) * | 2014-12-02 | 2021-10-26 | 艾维德洛公司 | 用于眼的交联治疗的系统、方法和组合物 |
| WO2016129654A1 (ja) * | 2015-02-12 | 2016-08-18 | 国立大学法人 東京大学 | 角膜内皮前駆細胞の調製方法 |
| ITUB20150108A1 (it) * | 2015-03-04 | 2016-09-04 | Alchilife S R L | Molecola antimicotica sintetica e metodo per sintetizzare una molecola antimicotica |
| PL3277083T3 (pl) | 2015-04-03 | 2025-05-26 | Vivalyx Gmbh | Zastosowanie kompozycji do prezerwacji narządów w celu prezerwacji narządu lub jego części |
| FR3035407B1 (fr) | 2015-04-23 | 2022-06-17 | Francais Du Sang Ets | Procede de conservation de cellules, tissus ou organes en hypothermie |
| FR3040860B1 (fr) * | 2015-09-10 | 2020-05-15 | Universite de Bordeaux | Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang peripherique |
| MX383940B (es) | 2015-12-09 | 2025-03-14 | Phosphagenics Ltd | Formulación farmacéutica que contiene tocol fosfato. |
| US11253551B2 (en) | 2016-01-11 | 2022-02-22 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction |
| WO2017210652A1 (en) | 2016-06-03 | 2017-12-07 | Cedars-Sinai Medical Center | Cdc-derived exosomes for treatment of ventricular tachyarrythmias |
| US10426796B2 (en) | 2016-06-13 | 2019-10-01 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
| US10456423B2 (en) | 2016-06-13 | 2019-10-29 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
| EP3515459A4 (de) | 2016-09-20 | 2020-08-05 | Cedars-Sinai Medical Center | Kardiosphärenzellen und deren extrazelluläre vesikel zur verzögerung oder umkehr des alterungsprozesses und altersbedingten erkrankungen |
| JP7198754B2 (ja) | 2016-12-21 | 2023-01-04 | アベーチョ バイオテクノロジー リミテッド | 方法 |
| US10265312B1 (en) * | 2018-02-01 | 2019-04-23 | Jason Ahee | Antibiotic solution and method of injection to prevent ophthalmic infections |
| CA3059910A1 (en) | 2017-04-19 | 2018-10-25 | Cedars-Sinai Medical Center | Methods and compositions for treating skeletal muscular dystrophy |
| US11660355B2 (en) | 2017-12-20 | 2023-05-30 | Cedars-Sinai Medical Center | Engineered extracellular vesicles for enhanced tissue delivery |
| WO2019152549A1 (en) | 2018-02-05 | 2019-08-08 | Cedars-Sinai Medical Center | Methods for therapeutic use of exosomes and y-rnas |
| CN108841780B (zh) * | 2018-06-29 | 2019-03-12 | 陕西诺威利华生物科技有限公司 | 适合大规模生产pedv疫苗的无血清培养基 |
| CN109801994B (zh) * | 2019-01-09 | 2020-11-24 | 成都中建材光电材料有限公司 | 一种提升碲化镉电池性能的方法 |
| US20220249399A1 (en) * | 2019-03-04 | 2022-08-11 | University Of Lowa Research Foundation | Composition comprising an anti-oxidant to preserve corneal tissue |
| US12624015B2 (en) | 2019-06-24 | 2026-05-12 | University Of Iowa Research Foundation | JNK inhibitors as anticancer agents |
| CN110278940A (zh) * | 2019-07-11 | 2019-09-27 | 河南省农业科学院畜牧兽医研究所 | 一种猪精子保存剂及其制备方法和应用 |
| CN114786481A (zh) * | 2019-11-29 | 2022-07-22 | 新泽西鲁特格斯州立大学 | 用于储存血液制品的组合物、试剂盒和方法及其使用方法 |
| WO2021108808A1 (en) | 2019-11-29 | 2021-06-03 | Rutgers, The State University Of New Jersey | Methods for isolating umbilical cord blood plasma products, tissue and cellular exosomes, and compositions and methods of use thereof |
| US11904006B2 (en) | 2019-12-11 | 2024-02-20 | University Of Iowa Research Foundation | Poly(diaminosulfide) particle-based vaccine |
| CN112602703B (zh) * | 2020-12-17 | 2022-05-27 | 中山大学附属第三医院 | 一种细胞、组织或器官冷保存液的制备方法与应用 |
| CN113508807B (zh) * | 2021-08-05 | 2022-03-04 | 信阳农林学院 | 一种卵巢常温保存液及其保存方法 |
| CN114190366B (zh) * | 2021-12-29 | 2023-04-07 | 松山湖材料实验室 | 冻存液及其制备方法与在人正常肝细胞的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1263606A (en) * | 1985-05-29 | 1989-12-05 | Jeffrey P. Gilbard | Non-toxic opthalmic preparations |
| CA2041828A1 (en) * | 1990-03-05 | 1992-11-04 | Richard L. Lindstrom | Viscoelastic solution |
| EP0516901A1 (de) * | 1991-06-06 | 1992-12-09 | Richard L. Lindstrom | Methode und Einrichtung für serumlose medizinische Lösung |
-
1998
- 1998-11-05 US US09/186,580 patent/US6153582A/en not_active Expired - Lifetime
-
1999
- 1999-10-28 AU AU57108/99A patent/AU769082B2/en not_active Ceased
- 1999-11-02 ES ES99308702T patent/ES2217700T3/es not_active Expired - Lifetime
- 1999-11-02 PT PT99308702T patent/PT1000541E/pt unknown
- 1999-11-02 DE DE69914160T patent/DE69914160T2/de not_active Expired - Lifetime
- 1999-11-02 EP EP99308702A patent/EP1000541B1/de not_active Expired - Lifetime
- 1999-11-02 AT AT99308702T patent/ATE257648T1/de active
- 1999-11-02 JP JP11313063A patent/JP2000198701A/ja active Pending
- 1999-11-03 CA CA2288540A patent/CA2288540C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2288540A1 (en) | 2000-05-05 |
| DE69914160D1 (de) | 2004-02-19 |
| ES2217700T3 (es) | 2004-11-01 |
| US6153582A (en) | 2000-11-28 |
| DE69914160T2 (de) | 2004-09-02 |
| EP1000541B1 (de) | 2004-01-14 |
| PT1000541E (pt) | 2004-08-31 |
| EP1000541A1 (de) | 2000-05-17 |
| JP2000198701A (ja) | 2000-07-18 |
| AU5710899A (en) | 2000-05-11 |
| CA2288540C (en) | 2011-07-05 |
| AU769082B2 (en) | 2004-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69914160D1 (de) | Definierte medizinische Lösung ohne Serum für die Augenheilkunde | |
| ATE129850T1 (de) | Definierte medizinische lösung ohne serum und deren verwendung. | |
| Kovačič et al. | Influence of atmospheric versus reduced oxygen concentration on development of human blastocysts in vitro: a prospective study on sibling oocytes | |
| Ross et al. | Enzymes of the γ-glutamyl cycle in the ciliary body and lens | |
| CA2164321A1 (en) | Plasma-like solution | |
| CA2338541A1 (en) | Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy | |
| IL190542A0 (en) | Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei | |
| BR9814568A (pt) | "inseminação sexual especìfica de mamìferos com baixo número de células espermatozóides" | |
| CN106854640A (zh) | 一种毛囊干细胞的无血清培养基及其制备方法 | |
| ES2162331T3 (es) | Utilizacion del factor de crecimiento del tejido nervioso para conservacion, cultivo o tratamiento de la cornea. | |
| Sandler et al. | Collodion baby and lamellar ichthyosis | |
| US5221537A (en) | Tissue irrigating solutions | |
| Marston et al. | Time relationships of spermatozoon penetration into the egg of the rhesus monkey | |
| Hassell et al. | Increased biosynthesis of specific glycoconjugates in rat corneal epithelium following treatment with vitamin A. | |
| Karlan et al. | Potentiation of infections by biomaterials: a comparison of three materials | |
| Boyd | Sodium sulfathiazole iontophoresis | |
| Nomura et al. | CIII The Capillary in the Human Vestibular Labyrinth: A Histochemical Staining Technique | |
| Cruz et al. | A staging scheme for assessing development in vitro of organogenesis stage embryos of the stripe-faced dunnart, Sminthopsis macroura (Marsupialia: Dasyuridae) | |
| Mössinger | In vitro cultivation of adult Litomosoides carinii: evaluation of basic culture media, gas phases and supplements | |
| Pincus | Qualitative tests on human enamel protein | |
| US4083991A (en) | Topical treatment of herpes infections with thimerosal | |
| O'Hare | Monolayer cultures of normal adult rat adrenocortical cells: steroidogenic responses to nucleotides, bacterial toxins and antimicrotubular agents | |
| Huang et al. | Effects of fertilization promoting peptide, adenosine, and pentoxifylline on thawed human sperm | |
| JPH1025201A (ja) | 歯牙保存液 | |
| Correa-Pérez | Embryo transfer medium—hyaluronic acid in place of albumin? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1000541 Country of ref document: EP |